The largest study to date has confirmed the link between the gut microbiome and the response to cancer immunotherapy therapy for melanoma.

The study is published today in Nature Medicine and co-ordinated by King’s College London, CIBIO Department of the University of Trento and European Institute of Oncology in Italy, University of Groningen in the Netherlands and funded by the Seerave Foundation.